Literature DB >> 21297072

Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.

Eilidh Mowat1, Steve Paterson, Joanne L Fothergill, Elli A Wright, Martin J Ledson, Martin J Walshaw, Michael A Brockhurst, Craig Winstanley.   

Abstract

RATIONALE: Pseudomonas aeruginosa isolates from chronic cystic fibrosis lung infections display multiple phenotypes indicating extensive population diversity.
OBJECTIVES: We aimed to examine how such diversity is distributed within and between patients, and to study the dynamics of single-strain phenotypic diversity in multiple patients through time.
METHODS: Sets of 40 P. aeruginosa isolates per sputum samples were analyzed for a series of phenotypic and genotypic characteristics. Population differentiation between patients, between samples within patients, and between isolates within samples was analyzed.
MEASUREMENTS AND MAIN RESULTS: We characterized 15 traits for a total of 1,720 isolates of an important and widely disseminated epidemic strain of P. aeruginosa from 10 chronically infected patients with cystic fibrosis multiply sampled during 2009. Overall, 43 sputum samples were analyzed and 398 haplotypes of the Liverpool Epidemic Strain were identified. The majority of phenotypic diversity occurred within patients. Such diversity is highly dynamic, displaying rapid turnover of haplotypes through time. P. aeruginosa populations within each individual sputum sample harbored extensive diversity. Although we observed major changes in the haplotype composition within patients between samples taken at intervals of several months, the compositions varied much less during exacerbation periods, despite the use of intravenous antibiotics. Our data also highlight a correlation between periods of pulmonary exacerbation and the overproduction of pyocyanin, a quorum sensing-controlled virulence factor.
CONCLUSIONS: These results significantly advance our understanding of the within-host population biology of P. aeruginosa during infection of patients with cystic fibrosis, and provide in vivo evidence for a link between pyocyanin production and patient morbidity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297072     DOI: 10.1164/rccm.201009-1430OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  115 in total

Review 1.  Cystic fibrosis papers of the year 2010-2011.

Authors:  David Honeybourne
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Genetic signature of bacterial pathogen adaptation during chronic pulmonary infections.

Authors:  Steve P Bernier; Matthew L Workentine; Michael G Surette
Journal:  Nat Genet       Date:  2014-01       Impact factor: 38.330

3.  Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.

Authors:  Jeremy R Dettman; Nicolas Rodrigue; Shawn D Aaron; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 4.  Pseudomonas aeruginosa polymicrobial interactions during lung infection.

Authors:  Karishma Bisht; Jiwasmika Baishya; Catherine A Wakeman
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

5.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

6.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

7.  Pseudomonas aeruginosa-Derived Rhamnolipids and Other Detergents Modulate Colony Morphotype and Motility in the Burkholderia cepacia Complex.

Authors:  Steve P Bernier; Courtney Hum; Xiang Li; George A O'Toole; Nathan A Magarvey; Michael G Surette
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

Review 8.  The cystic fibrosis airway microbiome.

Authors:  Susan V Lynch; Kenneth D Bruce
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 9.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

10.  Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts.

Authors:  Søren Damkiær; Lei Yang; Søren Molin; Lars Jelsbak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.